Literature DB >> 9669838

Ribosomal proteins sustain morphology, function and phenotype in acute myeloid leukemia blasts.

C F Bassøe1, O Bruserud, I F Pryme, A Vedeler.   

Abstract

Translation of mRNA is a prerequisite for cell proliferation, differentiation and viability. We have studied the effect of ribosome protein factors (GPRE) on acute myeloid leukemia (AML) blast cells. Ribosomes were isolated from MPC-11 cells using ultra-centrifugation. GPRE were extracted using a high KCl procedure. Blast cells from six AML patients were grown in suspension cultures for 24 and 96 h. GPRE or granulocyte macrophage-colony stimulating factor (GM-CSF) were added at the start of the incubation. GPRE, but not GM-CSF, prevented chromatin condensation and fragmentation of blast cell nuclei in AML-M2, -M4 and -M5 and the loss of nucleoli in AML-M2 and -M5. The fraction of phagocytosing blast cells in AML-M1, -M2, -M4 and -M5 was increased by GPRE. GPRE stimulated opsonin-dependent and -independent attachment and internalisation of N. meningitidis. GPRE increased the fraction of blasts expressing CD11b and CD32 in AML-M2 and -M5. GPRE diminished the fraction of AML-M5 cells bearing CD35 and CD32. GPRE also decreased the fraction of CD11c-bearing AML-M2 and -M5 cells. GM-CSF potentiated effects of GPRE in AML-M1, -M2, -M4 and -M5. GPRE and GM-CSF in combination affected phagocytosis and surface antigen expression in blast cells that were not influenced by either factor alone. Neither GPRE nor GM-CSF induced terminal differentiation or DNA-synthesis. We conclude that GPRE affects AML blast cell morphology, function and surface molecule expression, possibly by inhibiting apoptosis. The effects of GPRE may be mediated by ribosomal proteins that regulate translation and modulate the subcellular distribution of mRNA species.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9669838     DOI: 10.1016/s0145-2126(97)00178-1

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  4 in total

Review 1.  Nucleolar adaptation in human cancer.

Authors:  Leonard B Maggi; Jason D Weber
Journal:  Cancer Invest       Date:  2005       Impact factor: 2.176

2.  Relationship of differential gene expression profiles in CD34+ myelodysplastic syndrome marrow cells to disease subtype and progression.

Authors:  Kunju Sridhar; Douglas T Ross; Robert Tibshirani; Atul J Butte; Peter L Greenberg
Journal:  Blood       Date:  2009-10-02       Impact factor: 22.113

3.  Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation.

Authors:  Yaël Mamane; Emmanuel Petroulakis; Yvan Martineau; Taka-Aki Sato; Ola Larsson; Vinagolu K Rajasekhar; Nahum Sonenberg
Journal:  PLoS One       Date:  2007-02-21       Impact factor: 3.240

4.  Characterization and targeting of malignant stem cells in patients with advanced myelodysplastic syndromes.

Authors:  Brett M Stevens; Nabilah Khan; Angelo D'Alessandro; Travis Nemkov; Amanda Winters; Courtney L Jones; Wei Zhang; Daniel A Pollyea; Craig T Jordan
Journal:  Nat Commun       Date:  2018-09-12       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.